These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16254007)

  • 21. New onset atrial fibrillation after patent foramen ovale closure.
    Staubach S; Steinberg DH; Zimmermann W; Wawra N; Wilson N; Wunderlich N; Sievert H
    Catheter Cardiovasc Interv; 2009 Nov; 74(6):889-95. PubMed ID: 19626689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcatheter Amplatzer device closure of atrial septal defect and patent foramen ovale in patients with presumed paradoxical embolism.
    Khositseth A; Cabalka AK; Sweeney JP; Fortuin FD; Reeder GS; Connolly HM; Hagler DJ
    Mayo Clin Proc; 2004 Jan; 79(1):35-41. PubMed ID: 14708946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence, timing, and predictive factors of new-onset migraine headache attack after transcatheter closure of atrial septal defect or patent foramen ovale.
    Rodés-Cabau J; Mineau S; Marrero A; Houde C; Mackey A; Côté JM; Chetaille P; Delisle G; Bertrand OF; Rivest D
    Am J Cardiol; 2008 Mar; 101(5):688-92. PubMed ID: 18308022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and long-term results of patent foramen ovale transcatheter closure in patients with thrombophilia.
    Rigatelli G; Dell'Avvocata F; Giordan M; Camerotto A; Panin S; Ronco F; Cardaioli P
    Minerva Cardioangiol; 2009 Jun; 57(3):285-9. PubMed ID: 19513009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcatheter closure of patent foramen ovale in older adults.
    Kiblawi FM; Sommer RJ; Levchuck SG
    Catheter Cardiovasc Interv; 2006 Jul; 68(1):136-42; discussion 143-4. PubMed ID: 16755591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcatheter closure of patent foramen ovale with radiofrequency: acute and intermediate term results in 144 patients.
    Sievert H; Ruygrok P; Salkeld M; Baumgartner H; Meier B; Windecker S; Juliard JM; Aubry P; Tiefenbacher C; Krumsdorf U; Vermeersch P; Ewert P; Piéchaud JF
    Catheter Cardiovasc Interv; 2009 Feb; 73(3):368-73. PubMed ID: 19133667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patent foramen ovale: the evident paradox between the apparently simple treatment and the really complex pathophysiology.
    Rigatelli G
    J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):300-4. PubMed ID: 17413311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors and clinical outcomes of residual shunt in patients undergoing percutaneous transcatheter closure of patent foramen ovale.
    Zajarias A; Thanigaraj S; Lasala J; Perez J
    J Invasive Cardiol; 2006 Nov; 18(11):533-7. PubMed ID: 17090816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Percutaneous closure of patent foramen ovale, as secondary prevention of cryptogenic cerebral event].
    Temesvári A; Bálint OH; Liptai C; Kancz S; Németh B; Szatmári A
    Orv Hetil; 2006 Oct; 147(42):2035-9. PubMed ID: 17165604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of atrial fibrillation following transcatheter closure of atrial septal defects in adults.
    Spies C; Khandelwal A; Timmermanns I; Schräder R
    Am J Cardiol; 2008 Oct; 102(7):902-6. PubMed ID: 18805119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of results of percutaneous closure of patent foramen ovale for paradoxical embolism in patients with versus without thrombophilia.
    Giardini A; Donti A; Formigari R; Bronzetti G; Prandstraller D; Bonvicini M; Palareti G; Guidetti D; Gaddi O; Picchio FM
    Am J Cardiol; 2004 Oct; 94(8):1012-6. PubMed ID: 15476614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Percutaneous transcatheter closure of interatrial septal defect in adults: procedural outcome and long-term results.
    Kefer J; Sluysmans T; Hermans C; El Khoury R; Lambert C; Van de Wyngaert F; Ovaert C; Pasquet A
    Catheter Cardiovasc Interv; 2012 Feb; 79(2):322-30. PubMed ID: 21523898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrent events following patent foramen ovale closure in patients above 55 years of age with presumed paradoxical embolism.
    Spies C; Khandelwal A; Timmemanns I; Kavinsky CJ; Schräder R; Hijazi ZM
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):966-70. PubMed ID: 18942060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A suture not always the ideal solution: problems encountered in developing a suture-based PFO closure technique.
    Majunke N; Baranowski A; Zimmermann W; Heinisch C; Wilson N; Robertson G; Wunderlich N; Sievert H
    Catheter Cardiovasc Interv; 2009 Feb; 73(3):376-82. PubMed ID: 19085919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and brain magnetic resonance imaging follow-up after percutaneous closure of patent foramen ovale in patients with cryptogenic stroke.
    Vigna C; Inchingolo V; Giannatempo G; Pacilli MA; Di Viesti P; Fusilli S; Amico CM; Santoro T; Lanna P; Fanelli R; Simone P; Loperfido F
    Am J Cardiol; 2008 Apr; 101(7):1051-5. PubMed ID: 18359330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcatheter patent foramen ovale closure for secondary prevention of paradoxical embolic events: acute results from the FORECAST registry.
    Alameddine F; Block PC
    Catheter Cardiovasc Interv; 2004 Aug; 62(4):512-6. PubMed ID: 15274163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Chronic outcome of percutaneous transcatheter patent foramen ovale closure with Left-disk-coated patent foramen ovale occluder].
    Huang YG; Zhang CJ; Huang XS; Huang T; Huang WH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Dec; 37(12):1132-5. PubMed ID: 20193187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of cerebral embolism after interventional closure of symptomatic patent foramen ovale or atrial septal defect: a diffusion-weighted MRI and neuron-specific enolase-based study.
    Oktay Tureli H; Ungan I; Tureli D; Demir B; Pirhan O; Bayrak HI; Caglar IM; Karakaya O; Inci E
    J Invasive Cardiol; 2013 Oct; 25(10):519-24. PubMed ID: 24088426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atrial fibrillation following device closure of patent foramen ovale.
    Burow A; Schwerzmann M; Wallmann D; Tanner H; Sakata T; Windecker S; Meier B; Delacrétaz E
    Cardiology; 2008; 111(1):47-50. PubMed ID: 18239392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HELEX Septal Occluder for transcatheter closure of patent foramen ovale: multicentre experience.
    Billinger K; Ostermayer SH; Carminati M; Degiovanni JV; Ewert P; Hess J; Maymone-Martins FA; Qureshi SA; Salmon AP; Schneider M; Wilson N; Sievert H
    EuroIntervention; 2006 Feb; 1(4):465-71. PubMed ID: 19755222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.